Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum
Authors:
Open Access
- 27 June 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Abstract
Circulating proteins may provide insights into the varying biological mechanisms involved in heart failure (HF) with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). We aimed to identify specific proteomic patterns for HF, by comparing proteomic profiles across the ejection fraction spectrum. We investigated 4210 circulating proteins in 739 patients with normal (Stage A/Healthy) or elevated (Stage B) filling pressures, HFpEF, or ischemic HFrEF (iHFrEF). We found 2122 differentially expressed proteins between iHFrEF-Stage A/Healthy, 1462 between iHFrEF–HFpEF and 52 between HFpEF-Stage A/Healthy. Of these 52 proteins, 50 were also found in iHFrEF vs. Stage A/Healthy, leaving SLITRK6 and NELL2 expressed in lower levels only in HFpEF. Moreover, 108 proteins, linked to regulation of cell fate commitment, differed only between iHFrEF–HFpEF. Proteomics across the HF spectrum reveals overlap in differentially expressed proteins compared to stage A/Healthy. Multiple proteins are unique for distinguishing iHFrEF from HFpEF, supporting the capacity of proteomics to discern between these conditions.Keywords
Funding Information
- DCVA RECONNEXT
- EU/EFPIA Innovative Medicines Initiative 2 Joint Undertaking BigData@Heart
- Jaap Schouten Foundation
This publication has 62 references indexed in Scilit:
- Sex-Specific Cardiovascular Protein Levels and Their Link with Clinical Outcome in Heart FailureESC Heart Failure, 2023
- The HFA-PEFF Score Identifies ‘Early-HFpEF’ Phenogroups Associated with Distinct Biomarker ProfilesESC Heart Failure, 2022
- Growth Differentiation Factor 15 in Adverse Cardiac Remodelling: From Biomarker to Causal PlayerESC Heart Failure, 2020
- Insulin-like growth factor-1 signaling in cardiac agingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2)Clinical Cardiology, 2017
- Differentiating Heart Failure Phenotypes Using Sex-Specific Transcriptomic and Proteomic Biomarker PanelsESC Heart Failure, 2017
- The role of Wnt regulation in heart development, cardiac repair and disease: A tissue engineering perspectiveBiochemical and Biophysical Research Communications, 2016
- Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophagesAtherosclerosis, 2015
- Met signaling in cardiomyocytes is required for normal cardiac function in adult miceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Prognostic Value of Cystatin C on Admission in Heart Failure With Preserved Ejection FractionJournal of Cardiac Failure, 2011